Landec Corp expected to post a loss of 1  cent a share - Earnings Preview

Lifecore Biomedical

23/07/2022 02:19

* Landec Corp  LNDC.OQ   LNDC.O  is expected to show a fall
in
quarterly revenue when it reports  results on July 26
(estimated). 
    * The Santa Maria California-based  company is expected to
report 
a 67.4% decrease in revenue to $45.549 million from $139.83
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Landec Corp is for
a loss
of 1 cent per share. For the same quarter last year, the company
reported earnings of 7 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Landec Corp
is
$13.5​, above​ its last closing price of $10.29. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Feb. 28 2022  -0.01       0.00       -0.08     Missed  -1,500
 Nov. 30 2022  -0.04       -0.04      0.05      Beat    225
 Aug. 31 2021  -0.12       -0.12      -0.23     Missed  -98.3​
 May. 31 2021  -0.01       -0.01      0.07      Beat    975
 ​​Feb.        0.03        0.02       -0.09     Missed  -475
 28 2021                                                
 Nov. 30 2020  0.03        0.01       0.02      Beat    100​
 Aug. 31 2020  -0.12       -0.11      -0.11     Met     0
 May. 31 2020  0.03        0.03       0.05      Beat    81.8
 This summary was machine generated July 23 at 01:19 GMT.  All
figures in US dollars  unless otherwise stated